首页> 外文期刊>Biochemical and Biophysical Research Communications >Non-invasive stem cell tracking in hindlimb ischemia animal model using bio-orthogonal copper-free click chemistry
【24h】

Non-invasive stem cell tracking in hindlimb ischemia animal model using bio-orthogonal copper-free click chemistry

机译:使用生物正交无铜点击化学技术在后肢缺血动物模型中进行非侵入性干细胞追踪

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Labeling of stem cells aims to distinguish transplanted cells from host cells, understand in vivo fate of transplanted cells, particularly important in stem cell therapy. Adipose-derived mesenchymal stem cells (ASCs) are considered as an emerging therapeutic option for tissue regeneration, but much remains to be understood regarding the in vivo evidence. In this study, a simple and efficient cell labeling method for labeling and tracking of stem cells was developed based on bio-orthogonal copper free click chemistry, and it was applied in a mouse hindlimb ischemia model. The human ASCs were treated with tetra-acetylated N-azidoacetyl-D-mannosamine (Ac(4)ManNAz) to generate glycoprotein with unnatural azide groups on the cell surface, and the generated azide groups were fluorescently labeled by specific binding of dibenzylcyclooctyne-conjugated Cy5 (DBCO-Cy5). The safe and long-term labeling of the hASCs by this method was first investigated in vitro. Then the DBCO-Cy5-hASCs were transplanted into the hindlimb ischemia mice model, and we could monitor and track in vivo fate of the cells using optical imaging system. We could clearly observe the migration potent of the hASCs toward the ischemic lesion. This approach to design and tailor new method for labeling of stem cells may be useful to provide better understanding on the therapeutic effects of transplanted stem cells into the target diseases. (C) 2016 Elsevier Inc. All rights reserved.
机译:干细胞标记的目的是区分移植细胞和宿主细胞,了解移植细胞的体内命运,这在干细胞治疗中尤其重要。脂肪来源的间充质干细胞(ASC)被认为是一种用于组织再生的新兴治疗选择,但是就体内证据而言,还有许多地方尚待理解。在这项研究中,基于生物正交铜无点击化学,开发了一种简单有效的细胞标记方法,用于标记和追踪干细胞,并将其应用于小鼠后肢缺血模型。用四乙酰化N-叠氮基乙酰基-D-甘露糖胺(Ac(4)ManNAz)处理人类ASC,以产生在细胞表面具有非天然叠氮基团的糖蛋白,并通过二苄基环辛炔共轭物的特异性结合对生成的叠氮基团进行荧光标记Cy5(DBCO-Cy5)。首先在体外研究了通过这种方法对hASC的安全和长期标记。然后将DBCO-Cy5-hASCs移植到后肢缺血小鼠模型中,我们可以使用光学成像系统监测和追踪细胞的体内命运。我们可以清楚地观察到hASCs向缺血性病变的迁移能力。设计和定制用于标记干细胞的新方法的这种方法可能有助于更好地了解将干细胞移植到靶标疾病中的治疗效果。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号